Related Experiment Video

Updated: Aug 19, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Hyperlipidaemia in chronic kidney disease

C M Chan1

  • 1Department of Renal Medicine, Singapore General Hospital, Singapore. grmccm@sgh.com.sg

Annals of the Academy of Medicine, Singapore
|February 24, 2005
PubMed

Insights

Patients with chronic kidney disease (CKD) have high rates of dyslipidaemia, increasing cardiovascular disease risk. Aggressive LDL cholesterol management is crucial for these high-risk individuals.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Lipidology

Background:

  • Cardiovascular disease (CVD) is a leading cause of death in chronic kidney disease (CKD) patients.
  • Dyslipidaemia, particularly elevated low-density lipoprotein (LDL) cholesterol, is significantly more prevalent in CKD patients than the general population.
  • Most CKD patients die from CVD before progressing to end-stage renal disease.

Purpose of the Study:

  • To highlight the high prevalence of dyslipidaemia in CKD.
  • To emphasize the critical link between dyslipidaemia and CVD mortality in CKD.
  • To recommend screening and aggressive management of dyslipidaemia in CKD patients.

Main Methods:

  • Evaluation of dyslipidaemia in all CKD patients.
  • Measurement of complete fasting lipid profiles, including total cholesterol, LDL cholesterol, high-density lipoprotein cholesterol, and triglycerides.
  • Application of K/DOQI and NCEP ATP III guidelines for risk stratification and treatment.

Main Results:

  • CKD patients exhibit significantly higher levels of total and LDL cholesterol.
  • Dyslipidaemia is a major contributor to the elevated CVD risk in this population.
  • CKD patients are classified as a "very high risk" category for cardiovascular events.

Conclusions:

  • All patients with CKD require evaluation for dyslipidaemia.
  • Aggressive therapeutic intervention targeting LDL cholesterol is essential to mitigate cardiovascular risk in CKD.
  • Management strategies should align with established guidelines for high-risk individuals.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...